收藏切换
Evidence-based study on the efficacy of doxycycline for macrolide-resistant Mycoplasma pneumoniae pneumonia in Chinese children in the post-COVID-19 era
收藏切换
Tao SHEN, Wei LI, Xiaotian XIE*
World Clinical Drug | 2025, 46(9) : 952 - 957
Less
收藏切换
World Clinical Drug | 2025, 46(9): 952-957
• Article •
Evidence-based study on the efficacy of doxycycline for macrolide-resistant Mycoplasma pneumoniae pneumonia in Chinese children in the post-COVID-19 era
Full
Tao SHEN, Wei LI, Xiaotian XIE*
Affiliations
  • Department of Pediatrics, Tongji Hospital, Shanghai 200065, China
Published: 2025-09-10 doi: 10.13683/j.wph.2025.09.013
Outline
收藏切换
Objective

To investigate the therapeutic efficacy of doxycycline for macrolide-resistant Mycoplasma pneumoniae pneumonia(MRMP) in Chinese children after the corona virus disease 2019(COVID-19) pandemic.

Methods

Clinical data from MRMP studies in Chinese children over the past two years and the key parameters included clinical features(symptoms, signs, laboratory/imaging findings), drug efficacy and safety were collected through medical database searches. A systematic analysis evaluated the effectiveness and safety of doxycycline monotherapy for pediatric MRMP.

Results

A total of 200 pediatric MRMP cases were included. The overall effective rate of doxycycline was 88.5%(177/200), with fever reduction observed within 1.39 - 3.96 days after administration. No significant efficacy difference existed between severe Mycoplasma pneumoniae pneumonia group and non-severe Mycoplasma pneumoniae pneumonia group(83.1% vs. 91.1%, P>0.05). Adverse reactions to doxycycline occurred in only 5.5% of cases and were mild doxycycline significantly outperformed intravenous azithromycin in efficacy(92.6% vs. 67.6%, P<0.001), with comparable adverse reaction rates(7.4% vs. 9.5%, P>0.05).

Conclusion

Doxycycline has demonstrated significant clinical efficacy and good safety in pediatric MRMP. The infection rate of MRMP in children has continued to rise after COVID-19. Doxycycline provides a reliable intervention option for clinical use. Clinical application needs to enhance the ability to identify and diagnose MRMP in children at an early stage and continuously monitor possible long-term adverse drug reactions.

doxycycline  /  corona virus disease 2019  /  macrolide-resistant Mycoplasma pneumoniae pneumonia  /  azithromycin
沈陶, 李威, 谢晓恬. 多西环素对我国新冠疫情后儿童耐大环内酯类肺炎支原体肺炎疗效循证研究. 世界临床药物, 2025 , 46 (9) : 952 -957 . DOI: 10.13683/j.wph.2025.09.013
Tao SHEN, Wei LI, Xiaotian XIE. Evidence-based study on the efficacy of doxycycline for macrolide-resistant Mycoplasma pneumoniae pneumonia in Chinese children in the post-COVID-19 era[J]. World Clinical Drug, 2025 , 46 (9) : 952 -957 . DOI: 10.13683/j.wph.2025.09.013
Year 2025 volume 46 Issue 9
55
13
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2025.09.013
  • Receive Date:2025-03-23
  • Online Date:2026-11-09
  • Published:2025-09-10
Article Data
Affiliations
History
  • Received:2025-03-23
Affiliations
    Department of Pediatrics, Tongji Hospital, Shanghai 200065, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2025.09.013
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT